Medchemexpress LLC Epi-001 | 227947-06-0 | MFCD02683414 | 99.3% | 394.89 g·mol⁻¹ | C21H27ClO5 | 50 MG

Supplier:  Medchemexpress LLC HY10034850MG

EPI-001 is a small-molecule research compound that selectively inhibits the androgen receptor (AR) by targeting the amino-terminal domain transactivation unit 5 (Tau-5). It also functions as a selective PPARγ modulator and has demonstrated activity in castration-resistant prostate cancer models. Supplied as a solid analytical standard, it is suitable for biochemical, cell-based, and preclinical in vivo studies when used with recommended formulations and storage.

• Selective AR N-terminal domain inhibitor targeting Tau-5
• Inhibits AR transactivation with reported IC50 ≈ 6 μM
• Also acts as a selective PPARγ modulator
• High supplied purity (~99.3%) suitable for research
• Soluble in DMSO and formulatable for in vivo dosing
• Stable as powder at -20°C for long-term storage
• Available in small research quantities, e.g., 50 MG

Catalog No. 50-002-14458